A Midlands business partnership is bringing health technology to the UK to support businesses and consumers as the easing of lockdown restrictions begin.
Scientists from Fujita Health University in Japan have confirmed that low concentrations of ozone gas can be used to neutralise coronavirus particles without causing harm to humans.
According to the university research, low-level ozone gas in concentrations of 0.05 to 1.0 parts per million (ppm) could be key to neutralising the spread of coronavirus in healthcare settings such as examination rooms and waiting areas. It also provides businesses, vehicle users and households with an alternative method to sterilise the air and surfaces in their premises without the use of chemicals.
Medklinn International, the health technology company that has pioneered research and development into negative ionisation and ozone in the sterilisation process, already provides air and surface sterilisation solutions in ASIA, the USA, Canada, Australia and Germany. Now the business is set to launch in the UK.
Daniel Lu, chief technology and innovation officer of Medklinn International, said: “We are looking forward to bringing our health technology to the UK. The announcement from the team at Fujita Health University in Japan further demonstrates that ozone sterilisation technology is a viable alternative to the use of chemicals for disinfection.”
Steve Jones, Brand Manager Medklinn UK, said: “We’re really excited to be launching Medklinn UK. Our products are already used by some of the leading global brands in the travel and tourism, hospitality, F&B, education, retail and healthcare sectors including Hyatt, Mandarin Oriental and Singapore’s Changi Airport. We believe that they will be particularly useful to businesses, motorists and homeowners, as we make gradual steps towards easing restrictions and reopening the UK following the lockdowns over the past 12 months.”